PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totaling 33,408 shares, a decrease of 15.1% from the December 31st total of 39,338 shares. Based on an average daily volume of 132 shares, the short-interest ratio is presently 253.1 days. Based on an average daily volume of 132 shares, the short-interest ratio is presently 253.1 days.
PureTech Health Price Performance
OTCMKTS:PTCHF opened at $1.85 on Wednesday. The business has a fifty day simple moving average of $1.71 and a two-hundred day simple moving average of $1.70. PureTech Health has a 1 year low of $1.27 and a 1 year high of $1.90.
PureTech Health Company Profile
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Further Reading
- Five stocks we like better than PureTech Health
- Your Bank Account Is No Longer Safe
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
- 1 Hour Once A Day
- [No Brainer Gold Play]: “Show me a better investment.”
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
